200 related articles for article (PubMed ID: 29557942)
1. Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.
Neijenhuis M; Gevers TJG; Atwell TD; Gunneson TJ; Schimek AC; Kievit W; Drenth JPH; Kamath PS
Am J Gastroenterol; 2018 Apr; 113(4):567-575. PubMed ID: 29557942
[TBL] [Abstract][Full Text] [Related]
2. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
Bureau C; Adebayo D; Chalret de Rieu M; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rosi S; MacDonald S; Malago M; Stepanova M; Younossi ZM; Trepte C; Watson R; Borisenko O; Sun S; Inhaber N; Jalan R
J Hepatol; 2017 Nov; 67(5):940-949. PubMed ID: 28645737
[TBL] [Abstract][Full Text] [Related]
3. Six-minute walk test before and after large-volume paracentesis in cirrhotic patients with refractory ascites: A pilot study.
Makhlouf NA; Mahran ZG; Sadek SH; Magdy DM; Makhlouf HA
Arab J Gastroenterol; 2019 Jun; 20(2):81-85. PubMed ID: 31182343
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.
Gaba RC; Parvinian A; Casadaban LC; Couture PM; Zivin SP; Lakhoo J; Minocha J; Ray CE; Knuttinen MG; Bui JT
Clin Radiol; 2015 May; 70(5):e51-7. PubMed ID: 25758602
[TBL] [Abstract][Full Text] [Related]
5. MELD score and albumin replacement are related to higher costs during management of patients with refractory ascites.
Borges de Santana V; Bertocco de Paiva Haddad L; Morgado Conte T; Cortez Rizzon A; Miranda Barbosa V; Shield W; Andraus W; Augusto Carneiro D'Albuquerque L
Transplant Proc; 2014; 46(6):1760-3. PubMed ID: 25131030
[TBL] [Abstract][Full Text] [Related]
6. Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump.
Wong F; Bendel E; Sniderman K; Frederick T; Haskal ZJ; Sanyal A; Asrani SK; Capel J; Kamath PS
Liver Transpl; 2020 May; 26(5):651-661. PubMed ID: 31999044
[TBL] [Abstract][Full Text] [Related]
7. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
[TBL] [Abstract][Full Text] [Related]
8. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.
Pozzi M; Osculati G; Boari G; Serboli P; Colombo P; Lambrughi C; De Ceglia S; Roffi L; Piperno A; Cusa EN
Gastroenterology; 1994 Mar; 106(3):709-19. PubMed ID: 8119542
[TBL] [Abstract][Full Text] [Related]
9. RESPIRATORY AND SYMPTOMATIC IMPACT OF ASCITES RELIEF BY PARACENTESIS IN PATIENTS WITH HEPATIC CIRRHOSIS.
Wittmer VL; Lima RT; Maia MC; Duarte H; Paro FM
Arq Gastroenterol; 2020; 57(1):64-68. PubMed ID: 32294737
[TBL] [Abstract][Full Text] [Related]
10. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites.
Easson AM; Bezjak A; Ross S; Wright JG
Ann Surg Oncol; 2007 Aug; 14(8):2348-57. PubMed ID: 17505860
[TBL] [Abstract][Full Text] [Related]
11. Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients.
Riedel AN; Kimer N; Jensen AH; Dahl EK; Israelsen M; Aamann L; Gluud LL
World J Gastroenterol; 2018 Apr; 24(15):1650-1657. PubMed ID: 29686472
[TBL] [Abstract][Full Text] [Related]
12. Predicting dry weight in patients with cirrhotic ascites undergoing large-volume paracentesis.
Alves BC; Luchi-Cruz MM; Lopes AB; Saueressig C; Dall'Alba V
Clin Nutr ESPEN; 2023 Apr; 54():34-40. PubMed ID: 36963881
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.
Neijenhuis MK; Gevers TJ; Hogan MC; Kamath PS; Wijnands TF; van den Ouweland RC; Edwards ME; Sloan JA; Kievit W; Drenth JP
Hepatology; 2016 Jul; 64(1):151-60. PubMed ID: 26970415
[TBL] [Abstract][Full Text] [Related]
14. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.
Stepanova M; Nader F; Bureau C; Adebayo D; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rossi S; MacDonald S; Capel J; Jalan R; Younossi ZM
Qual Life Res; 2018 Jun; 27(6):1513-1520. PubMed ID: 29460201
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites.
Ontanilla-Clavijo G; Ampuero J; Borreguero S; Rosell J; Romero-Gómez M
Rev Esp Enferm Dig; 2019 Mar; 111(3):223-227. PubMed ID: 30511576
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis.
Wong F; Gines P; Watson H; Horsmans Y; Angeli P; Gow P; Minini P; Bernardi M
J Hepatol; 2010 Aug; 53(2):283-90. PubMed ID: 20541828
[TBL] [Abstract][Full Text] [Related]
17. Ascites symptom inventory-7 is a valuable tool for evaluating the effectiveness of tolvaptan in patients with cirrhotic ascites.
Kawaratani H; Moriya K; Namisaki T; Shimozato N; Kaji K; Takaya H; Fujinaga Y; Sawada Y; Sato S; Saikawa S; Kubo T; Akahane T; Fukui H; Yoshiji H
Exp Ther Med; 2021 Jan; 21(1):30. PubMed ID: 33262816
[TBL] [Abstract][Full Text] [Related]
18. TIPS versus paracentesis for cirrhotic patients with refractory ascites.
Saab S; Nieto JM; Ly D; Runyon BA
Cochrane Database Syst Rev; 2004; (3):CD004889. PubMed ID: 15266548
[TBL] [Abstract][Full Text] [Related]
19. Large-volume paracentesis in the treatment of cirrhotic patients with refractory ascites. The role of postparacentesis plasma volume expansion.
Forouzandeh B; Konicek F; Sheagren JN
J Clin Gastroenterol; 1996 Apr; 22(3):207-10. PubMed ID: 8724259
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Edmonton Symptom Assessment System: Ascites Modification.
Mori M; Morita T; Yokomichi N; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
J Pain Symptom Manage; 2018 Jun; 55(6):1557-1563. PubMed ID: 29581035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
